The molecular analysis demonstrated that SPP1 gene amplification was the highest genetic alteration of SPP1 across many cancer types, whereas the frequency of SPP1 mutation (missense mutation) was low in bladder cancer compared to uterine, skin, lung, cervical, gastric and colorectal cancers. This evidence concerns the gene SPP1 and colorectal cancer.